Holen Sie sich die Stockscreener-App
9.36
2.80%
-0.27
Pharming Group Nv Adr Aktie (PHAR) Neueste Nachrichten
Zai Lab LimitedADR Peer Comparison – Compare with Others - valueresearchonline.com
PHAR Q2 2026 Earnings: EPS Falls 90% Short of ConsensusAnalyst Drop Coverage - careplusvn.com
PHAR Q2 2026 Earnings: EPS Falls 90% Short of ConsensusEarnings Season Preview - dars.gov.et
PHAR Q2 2026 Earnings: EPS Falls 90% Short of ConsensusBalance Sheet Strength - dars.gov.et
Pharming Group (PHAR) Slips 3.22% to $11.11: Key Support Zone in FocusHagopian Line - careplusvn.com
Pharming Group (PHAR) Slips 3.22% to $11.11: Key Support Zone in FocusDescending Triangle - dars.gov.et
Pharming Group (PHAR) Slips 3.22% to $11.11: Key Support Zone in FocusOversold Bounce Ideas - dars.gov.et
XORTX Therapeutics Inc. (XRTX) Peer Comparison – Compare with Others - Value Research
Pharming (PHAR) Quarterly Results: The EPS Result Is Below Expectation in the Latest Session; Investor Response: Shares Move Lower 0.30% in the Current UpdateSlow Growth Warning - dars.gov.et
Pharming (PHAR) EPS and Revenue: The Bottom-Line Figure Trails Its Comparison under the Current Snapshot; After Earnings: The Market Price Declines 1.43% on the DayEarnings Preview - dars.gov.et
Pharming (PHAR) EPS and Revenue: The Bottom-Line Figure Trails Its Comparison under the Current Snapshot; After Earnings: The Market Price Declines 1.43% on the DayMargin Expansion Trends - dars.gov.et
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Short Interest Up 93.0% in July - MarketBeat
Pharming Group (PHAR) Slides 5.1% to $11.72 as Rare-Disease Biotech Faces Selling PressureTrading Ideas - careplusvn.com
Pharming Group (PHAR) Slides 5.1% to $11.72 as Rare-Disease Biotech Faces Selling PressureInsider Selling Alerts - dars.gov.et
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Given Average Rating of "Hold" by Brokerages - MarketBeat
Pharming Group (NASDAQ:PHAR) Shares Gap DownShould You Sell? - MarketBeat
Pharming Group (NASDAQ:PHAR) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Pharming (PHAR) Q2 2026 Earnings: 90% EPS Miss Overshadowed by Resilient Share PriceRevenue Warning Signal - careplusvn.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Pharming Grou - The National Law Review
Pharming Group (PHAR) Securities Investigation NoticeLevi & Korsinsky - Sahm
Pharming Group (NASDAQ:PHAR) Shares Gap UpTime to Buy? - MarketBeat
Pharming Group (PHAR) Advances 1.93% to $10.01, Approaches Key Resistance at $10.51IV Spike - careplusvn.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Q3 EPS Estimates for Pharming Group Lowered by HC Wainwright - MarketBeat
PHAR Q2 2026 Earnings: Marginal EPS Miss Triggers 15.5% SelloffCFO Commentary Report - careplusvn.com
Pharming Group (NASDAQ:PHAR) Shares Gap Down Following Weak Earnings - MarketBeat
PHAR Q2 2026 Earnings: Marginal EPS Miss Triggers 15.5% SelloffSurprise Factor Analysis - dars.gov.et
PHAR Q2 2026 Earnings: Marginal EPS Miss Triggers 15.5% SelloffEarnings Surprise Score - https://www.dars.gov.et/
Pharming Q2 2026 slides: Joenja growth offsets RUCONEST pressure - investing.com
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Short Interest Update - MarketBeat
Pharming Group NV Sponsored ADR Revenue Breakdown – DUS:PHG - TradingView
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Given Average Rating of "Hold" by Analysts - MarketBeat
Pharming Group (NASDAQ:PHAR) Shares Gap DownHere's What Happened - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Pharming Group N.V - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Pharming Group N.V - The National Law Review
A2QLQY Forecast — Price Target — Prediction for 2027 - TradingView
Pharming Group NV Sponsored ADR Actuals & Estimates (NASDAQ:PHAR) - TradingView
PHG Forecast — Price Target — Prediction for 2027 - TradingView
PHG Forecast — Price Target — Prediction for 2027 - TradingView
PHG Forecast — Price Target — Prediction for 2027 - TradingView
A2QLQY Forecast — Price Target — Prediction for 2027 - TradingView
PHG Forecast — Price Target — Prediction for 2027 - TradingView
PHG Forecast — Price Target — Prediction for 2027 - TradingView
DBV Technologies (DBVT) soars 5.3%: Is further upside left in the stock? - MSN
DBV Technologies (DBVT) soars 5.3%: Is further upside left in the stock? - MSN
DBV Technologies (DBVT) soars 5.3%: Is further upside left in the stock? - MSN
DBV Technologies (DBVT) Soars 5.3%: Is Further Upside Left in the Stock? - Yahoo Finance
Form 6K Pharming Group NV For: 28 May By Investing.com - Investing.com South Africa
8.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):